Engineering Microorganisms for Cancer Immunotherapy
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202304649 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Dingkang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Genetic Engineering. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 232 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Cancer immunotherapy presents a promising approach to fight against cancer by utilizing the immune system. Recently, engineered microorganisms have emerged as a potential strategy in cancer immunotherapy. These microorganisms, including bacteria and viruses, can be designed and modified using synthetic biology and genetic engineering techniques to target cancer cells and modulate the immune system. This review delves into various microorganism‐based therapies for cancer immunotherapy, encompassing strategies for enhancing efficacy while ensuring safety and ethical considerations. The development of these therapies holds immense potential in offering innovative personalized treatments for cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing, 211198,…
- Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital, Nanjing, 210009, China.
- Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, No. 120 Longshan Road, Chongqing, 401147, China.
ORCID-Profile: Dingkang Liu, Jun Yin
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Liu, D., Yu, L., Rong, H., Liu, L., & Yin, J. (2024). Engineering Microorganisms for Cancer Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304649
Vancouver
Liu D, Yu L, Rong H, Liu L, Yin J. Engineering Microorganisms for Cancer Immunotherapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304649
BibTeX
@article{Liu2024,
author = {Liu, Dingkang and Yu, Lichao and Rong, Haibo and Liu, Lubin and Yin, Jun},
title = {Engineering Microorganisms for Cancer Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202304649}
}
EUVIMED